Expression of fusion protein of HIV envelope and HBsAg
US5130248A · kind A · utility
2Cited by
0References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 19, 1989 |
| Grant date | Jul 14, 1992 |
| Priority date | — |
| Expiry date | Sep 19, 2009 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/16222
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to recombinant fusion polypeptides of HIV envelope and HBsAg, suitable as vaccines against AIDS and/or ARC and hepatitis, as well as immunogens for inducing antibodies for passive protection or treatment of AIDS and/or ARC.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.